The type 3 iodothyronine deiodinase (D3) metabolizes thyroid hormones to inactive metabolites in many tissues, including the brain. In the present studies, we have examined the mechanisms by which T 3 (T 3 ), retinoic acid, 12-O-tetradecanoyl phorbol 13-acetate (TPA), and basic fibroblast growth factor (bFGF) induce D3 expression in primary cultures of neonatal rat astrocytes. In untreated cells, D3 messenger RNA (mRNA) was essentially undetectable by Northern analysis and RT-PCR. However, all four agents induced expression of a 2.4-kb D3 transcript as well as D3 activity. Induction of D3 by TPA and bFGF was more rapid than that by T 3 and retinoic acid, and T 3 potentiated the stimulatory effects of TPA and bFGF. D3 induction by TPA was blocked by GF 109203X, an inhibitor of protein kinase C. In addition, the effects of TPA and bFGF were partially prevented by PD 98059, a specific inhibitor of MEK and the Erk signaling cascade. These studies demonstrate that multiple growth factors and hormones regulate D3 activity in cultured astrocytes by inducing D3 mRNA expression. In addition, the stimulatory effects of TPA and bFGF on D3 mRNA and activity appear to be mediated at least in part by activation of the MEK/Erk signaling cascade. (Endocrinology 140: [2917][2918][2919][2920][2921][2922][2923] 1999) T HYROID HORMONES are essential for normal growth and maturation of the mammalian central nervous system (1). The effects of these hormones in any given tissue are dependent on their rates of cellular entry and metabolism. In the brain the type 2 deiodinase (D2) serves the important role of converting T 4 to T 3 , the metabolically most active thyroid hormone, by 5Ј-deiodination. In contrast, the type 3 deiodinase (D3) metabolizes T 4 and T 3 to the inactive metabolites rT 3 and 3,3Ј-diiodothyronine, respectively, via 5-deiodination (2). The balance between these activating and inactivating processes appears to play a critical role in regulating thyroid hormone action in this tissue (3).
the stimulatory effects of TPA and bFGF. D3 induction by TPA was blocked by GF 109203X, an inhibitor of protein kinase C. In addition, the effects of TPA and bFGF were partially prevented by PD 98059, a specific inhibitor of MEK and the Erk signaling cascade. These studies demonstrate that multiple growth factors and hormones regulate D3 activity in cultured astrocytes by inducing D3 mRNA expression. In addition, the stimulatory effects of TPA and bFGF on D3 mRNA and activity appear to be mediated at least in part by activation of the MEK/Erk signaling cascade. (Endocrinology 140: [2917] [2918] [2919] [2920] [2921] [2922] [2923] 1999) T HYROID HORMONES are essential for normal growth and maturation of the mammalian central nervous system (1) . The effects of these hormones in any given tissue are dependent on their rates of cellular entry and metabolism. In the brain the type 2 deiodinase (D2) serves the important role of converting T 4 to T 3 , the metabolically most active thyroid hormone, by 5Ј-deiodination. In contrast, the type 3 deiodinase (D3) metabolizes T 4 and T 3 to the inactive metabolites rT 3 and 3,3Ј-diiodothyronine, respectively, via 5-deiodination (2) . The balance between these activating and inactivating processes appears to play a critical role in regulating thyroid hormone action in this tissue (3) .
Complementary DNAs (cDNAs) for the D2 and D3 from several mammalian species have recently been isolated and shown to code for proteins containing the uncommon amino acid selenocysteine at the active catalytic site (4 -6) . The importance of selenium for deiodination in astroglial cells has recently been demonstrated; the expression of both D2 and D3 in these cells is markedly impaired by selenium deprivation (7, 8) . Factors that alter cellular processes through signaling cascades originating at the plasma membrane have been demonstrated also to have important effects on the levels of deiodinase activity in these cells. For example, D3 activity is markedly and rapidly induced by 12-Otetradecanoyl phorbol-13-acetate (TPA) and by acidic and basic fibroblast growth factors (aFGF and bFGF, respectively) (9) . Other growth factors (e.g. epidermal growth factor and platelet-derived growth factor) as well as cAMP analogs and forskolin have significant, although quantitatively lesser, stimulatory effects on glial cell D3 activity (9) . In addition, ligands for certain nuclear receptors, most notably retinoic acid (RA) and thyroid hormones, have important effects on D3 activity levels (10, 11) .
Only limited information is available concerning the mechanisms of D3 regulation. Recently, the induction of D3 messenger RNA (mRNA) levels by various growth factors in primary cultures of rat brown adipocytes has been described (12) . However, the effects of these and other agents on D3 transcript levels in the central nervous system have not been reported, nor is it known what pathways mediate the TPAand growth factor-induced stimulation of this enzyme. TPA is known to initiate signaling by activation of certain protein kinase C (PKC) isoforms, whereas FGF's effects are mediated through activation of its receptor's tyrosine kinase (13) . These proximal events, in turn, stimulate several intracellular signaling cascades. A downstream pathway induced by both TPA and growth factors in astrocytes and other cell systems is the Raf/MEK/Erk cascade (14, 15) . This pathway is responsible for the phosphorylation of many target proteins in response to stimulation by mitogens and growth factors and has been shown to be involved in the regulation of several genes (16 -19) . In particular, the Raf/MEK/Erk cascade has been documented to alter gene expression through effects on transcription from the serum response element (20) .
In the present studies, we have examined the effects of T 3 , RA, TPA, and bFGF on the expression of D3 mRNA in cultured astroglial cells. Furthermore, we provide evidence that the MEK/Erk signaling cascade is probably an important mediator of D3 induction by TPA and bFGF. 
Materials and Methods

Animals and reagents
Cell culture conditions
Brains were removed from 2-day-old Sprague Dawley rats and cleaned of meninges and blood vessels. Two cerebral hemispheres were then dissociated to form a cell suspension by passage through a nylon mesh (82-m pore size) into 40 ml DMEM supplemented with 6 g/liter glucose, 2.4 g/liter sodium bicarbonate, antibiotics (100 U/ml penicillin, 100 g/liter streptomycin, and 0.25 g/liter amphotericin), and 10% FCS (DMEM-FCS). Aliquots (3 ml) of this cell suspension were placed in 60-mm petri dishes, and the cultures were maintained at 37 C under 5% CO 2 -95% air and more than 90% humidity. The medium was changed every 2-3 days until cells reached confluence at about 10 days. At this stage, the DMEM-FCS was removed, and the cells were washed with a chemically defined medium (a 1:1 mixture of DMEM and Ham's F-12 medium (DMEM/F12) supplemented with 5.2 g/liter glucose, 1.8 g/liter sodium bicarbonate, and the antibiotics listed above). The cells were then cultured for 3 additional days in DMEM/F12 supplemented with 30 nm sodium selenite, 10 g/ml insulin, and 10 g/ml transferrin followed by 1 additional day in DMEM/F12 supplemented with 30 nm sodium selenite, 1 m cortisol, and 10 g/ml transferrin. Under these culture conditions, 95% of the cells contain immunoreactive glial fibrillary acidic protein (11), a specific marker of astrocytes. Cultured astrocytes were treated with the test agents for the times and at the concentrations indicated in each experiment.
Cell harvesting and D3 assay
At the time of harvesting, the medium was aspirated, and the cells were rinsed twice with 3 ml ice-cold PBS. Culture dishes containing the cells were then frozen at Ϫ80 C for later processing and analysis. This involved placing the plates on ice, scraping the content of each dish into 0. 125 I]T 3 by descending paper chromatography (21) . Deiodination was linear with both protein and time, and the quantity of protein assayed was adjusted to ensure that less than 30% of the substrate was consumed. Data represent the mean from either two or three dishes Ϯ sd. D3 activity assays were repeated in three separate experiments.
RNA preparation and Northern analysis
RNA was prepared from cultured glial cells by the method of Chomczynski and Sacchi (22) . Polyadenylated RNA was isolated by one cycle of chromatography over oligo(deoxythymidine)-cellulose. Northern analysis was performed using methods previously described (23) . In brief, Northern blots were hybridized overnight at 42 C in 15 ml hybridization buffer [50% deionized formamide, 5 ϫ saline-sodium phosphate-EDTA buffer (pH 7.4), 0.1% SDS, and 5 ϫ Denhardt's solution] containing 100 g/ml salmon sperm DNA and 1.5 million cpm/ml cDNA probe. The final wash was performed at 60 C for 60 min in 0.1 ϫ SSC-0.1% SDS. After hybridization and analysis with the D3-specific probe, blots were stripped and reprobed with a rat ␤-actin probe. Hybridization signals were quantified by densitometry, and the ratio of D3 to ␤-actin mRNA was calculated.
The D3 cDNA probe was prepared by EcoRI digestion of the plasmid containing the rNS27-1 rat D3 cDNA (4). This generated a 1562-bp fragment that contains the majority of the coding region and the 3Ј-untranslated region of the D3 mRNA. The fragment was separated on low melt agarose gel and stained with ethidium bromide; the appropriate band was excised and then labeled with 32 P.
Erk [mitogen-activated protein (MAP) kinase] assay
Erk (MAP kinase) activity was measured by incubating 5 l astrocyte extract, prepared as previously described (14, 24) , for 10 min at 30 C in a final volume of 50 l containing 20 mm HEPES (pH 7.4), 5 mm MgCl 2 , 2 mm EGTA, 2 mm DTT, 1 mm Na 3 VO 4 , 20 m [␥-
32 P]ATP (3 Ci/mmol), 17 g myelin basic protein, and 10 g/ml of the protein kinase A peptide inhibitor. The reaction was initiated by adding an aliquot of the extract and was stopped by spotting 40 l of the reaction mixture onto Whatman 3MM paper (Whatman, Clifton, NJ). The papers were washed once with 10% trichloroacetic acid containing 3 mm ATP (for at least 1 h) and three times with 5% trichloroacetic acid, dried with ethanol-ether and then ether alone, and finally counted for radioactivity.
RT-PCR assay
RT-PCR was used in some experiments to study the induction of D3 mRNA. RT was performed with 50, 100, and 200 ng total RNA for each sample in a 20-l reaction volume containing 1 mm DTT, 0.5 mm dNTP mix, 1 m of random primers, 200 U recombinant ribonuclease inhibitor, 1 ϫ first strand buffer, and 200 U MMLV reverse transcriptase. After a 1-h incubation at 42 C, 5 l of each RT mixture were used for the PCR. The PCR reaction was performed in 50 l containing 0.2 mm dNTPs, 0.1 Ci [␣-32 P]dCTP, 0.4 m of sense and antisense primers (see sequence below), 2.6 U Expand High Fidelity PCR System, and 1 ϫ Expand High Fidelity buffer containing 1.5 mm MgCl 2 . Thirty cycles of PCR were employed, with an annealing temperature of 64 C. The oligonucleotide primers were derived from the coding region of the rat D3 cDNA. These were: sense, 5Ј-CCCTGCTGCTTCACTCTCTG-3Ј; and antisense, 5Ј-GGTCCCTTGTGCGTAGTCGA-3Ј. An amplification product of 386 bp was expected. Products were separated on an 0.8% agarose gel and transferred to a nylon membrane, and the quantity of radiolabeled nucleotide incorporated was determined using the Instant Imager (Packard Instrument Co., Meriden, CT) analysis. For each sample, the quantity of PCR product derived was a linear function of the initial amount of RNA added over the range examined (50 -200 ng). Control PCR reactions using as template 5 l reverse transcriptase mixtures lacking either RNA or MMLV yielded no product. The integrity of the RNA samples used in the RT-PCR reactions was demonstrated by observing intact 18S and 28S ribosomal RNA bands on agarose gel electrophoresis.
As an additional control, another PCR amplification was performed on each sample using a 5-or 2.5-l aliquot from the 50-ng reverse transcriptase mixture and oligonucleotide primers derived from the S26 ribosomal protein sequence (sense, 5Ј-GTGCGTGCCCAAGGATAAGG-3Ј; antisense, 5Ј-ATGGGCTTTGGTGGAGGTCG-3Ј) (25) . An amplification product of 261 bp was expected. PCR conditions and the methods of product analysis were the same as described above.
Protein determination
The protein content of cell sonicates was determined by the method of Bradford (26) using BSA as standard.
Results
Effects of T 3 , RA, TPA, and bFGF on D3 mRNA levels
We previously demonstrated that TPA and RA are potent inducers of D3 activity in cultured astroglial cells, and that bFGF and thyroid hormones also have significant, although lesser, stimulatory effects (9 -11) . Initial studies were conducted to examine the effects of these agents, singly and in combination, on D3 mRNA levels. In all experiments and under all treatment conditions, Northern analysis revealed the presence of a single 2.4-kb transcript (see below), a finding consistent with the size of the D3 mRNA previously observed in rat placenta and neonatal skin (4) .
The induction of D3 activity by both 10 nm T 3 ( Fig. 1 ) and 1 m RA ( Fig. 2A) was relatively slow; activity progressively increased for 48 h after treatment with these agents. In contrast, a marked increase in D3 activity was noted by 7 h in cells treated with 100 nm TPA ( Fig. 2A) . D3 mRNA also increased after 24 and 48 h of T3 and RA treatment. These levels, however, were significantly less than those noted in the cells treated with TPA despite the fact that RA and TPA induced D3 activity to a comparable extent in this experiment. To verify that RA does stimulate D3 mRNA, glial cell total RNA was subjected to RT-PCR, a more sensitive method of RNA analysis. Using this technique, an increase in D3 transcript levels was noted as early as 2 h after exposure to RA, and this persisted for 24 h (Fig. 2B ). This was a consistent finding in several experiments, although the results cannot be evaluated in a strictly quantitative fashion using the RT-PCR technique that was employed (27) .
As shown in Fig. 3 , T 3 and TPA were noted to have synergistic effects on stimulating both D3 activity and mRNA levels; preincubating astrocytes for 24 h with 10 nm T 3 markedly potentiates the stimulatory effect of 100 nm TPA. The time course of this inductive effect is shown in Fig. 4 where cells were preincubated with 10 nm T 3 for 24 h and then stimulated with TPA and harvested immediately or 2, 5, 7, or 12 h later. Consistent with our prior results (9), a small increase in D3 activity was noted at 5 h after TPA addition, whereas a marked increase to near-maximal levels was noted at 7 h (Fig. 4A) . Stimulation of D3 mRNA levels appeared to precede the rise in enzyme activity; Northern analysis detected an increase in transcript levels at the 2 h point and a strong induction by 5 h (Fig. 4B ). Transcript levels appeared to peak at 7 h and then markedly declined, such that at 12 h, the D3 mRNA level had nearly returned to that noted in the basal state. However, D3 activity was still high at this time point, suggesting that the D3 protein is relatively stable in cultured astrocytes. This inference is consistent with our prior observations (7) .
Previous studies have demonstrated that the time course of D3 induction by bFGF is quite rapid and similar to that of FIG. 1. Induction of D3 mRNA and activity by T 3 . Astrocytes were cultured with 10 nM T 3 for 0, 12, 24, or 48 h, then were harvested for the determination of D3 mRNA levels and D3 activity. Membranes for Northern analysis were hybridized successively with a 32 P-labeled D3 cDNA and a 32 P-labeled ␤-actin cDNA followed by autoradiography as described in Materials and Methods. Based on densitometry determinations from this analysis, the ratios of D3 to ␤-actin mRNAs for the four time points were 0.00, 0.00, 0.03, and 0.07, respectively.
FIG. 2.
Induction of D3 mRNA and activity by RA and TPA. A, Astrocytes were treated with 1 M RA for 0, 24, or 48 h or with 100 nM TPA for 7 h. Cells were then harvested, and assays were performed for D3 activity and mRNA levels by Northern analysis as described in Fig. 1 . Relatively low levels of a 2.4-kb transcript were induced by RA treatment. The ratios of D3 to ␤-actin mRNAs for the four experimental conditions were 0.00, 0.02, 0.07, and 0.59, respectively. B, Astrocytes were treated for 2-24 h with 1 M RA before harvesting. In this experiment, D3 mRNA expression was assessed using an RT-PCR assay as described in Materials and Methods. D3-specific primers amplified a 386-bp fragment using total RNA as a template in this assay. As a positive control, amplification of the S26 ribosomal protein RNA was performed in a separate reaction using the same RNA samples and primers specific for this mRNA.
TPA (9, 10) . This is demonstrated in Fig. 5 where both D3 activity and mRNA are shown to be markedly elevated after treating astroglial cells with this growth factor for 7 h. In addition, the stimulatory effects of T 3 and bFGF on D3 activity and mRNA appeared to be greater than additive, as was the case with T 3 and TPA. Of interest in Fig. 5 is the finding that D3 activity was induced to similar levels by treatment of cells with either T 3 for 24 h or with bFGF for 7 h. However, the induction of D3 mRNA was much less with the former agent. This is similar to the finding presented in Fig.  2A that very modest levels of D3 mRNA induction by RA were accompanied over a period of 24 -48 h by a large increase in D3 activity.
Effects of inhibition of the MEK/Erk cascade on D3 induction by growth factors and hormones
The above studies demonstrated that mitogens and growth factors known to transduce signals from the cell surface as well as ligands that interact with nuclear receptors induce both D3 mRNA and activity levels. To begin to dissect out the signaling cascades mediating these effects, we conducted experiments using two pharmacologic inhibitors. GF 109203X is a staurosporine-related bisindolylmaleimide and is a potent and specific inhibitor of classical PKC isoforms (e.g. ␣, ␤1, ␤2, and ␥) (28, 29) . PD 98059 is a specific inhibitor of the Erk-activating kinase (MEK) when used at concentrations below 50 m (30).
When astrocytes were preincubated for 30 min with relatively low concentrations (1 m) of GF 109203X, induction of D3 activity by 100 nm TPA was almost completely blocked (Fig. 6A) . This finding is consistent with the effects of TPA on D3 induction being mediated through classical PKC isoforms. In contrast, stimulation of D3 activity by bFGF was impaired by only 30% in the presence of 1 m GF 109203X. At higher concentrations of this inhibitor (5 m), a greater degree of inhibition (ϳ70%) was noted (Fig. 6B) . That these inhibitory effects of GF 109203X were not due to nonspecific toxicity was demonstrated in other studies in which the treatment of cells with this agent did not impair the induction of D3 activity by cAMP-stimulating agents such as forskolin (Pallud, S., and F. Courtin, unpublished data).
Preincubation of cells for 30 min with the MEK inhibitor PD 98059 at concentrations between 5-50 m impaired the by TPA in T 3 -treated astrocytes. Cultured astrocytes were treated for 24 h with 10 nM T 3 and then for various times, as indicated, with 100 nM TPA. At each time, D3 activity and D3 mRNA were assayed as described in Fig. 1 . The ratios of D3 to ␤-actin mRNAs for the five time points were 0.02, 0.14, 1.19, 2.33, and 0.18, respectively.
FIG. 5. Effects of T 3 and FGF on the induction of D3 expression.
Cultured astrocytes were treated with or without 10 nM T 3 for 24 h. bFGF (20 ng/ml) was added for the last 7 h before harvesting. The ratios of D3 to ␤-actin mRNAs for the four experimental conditions were 0.00, 0.03, 0.32, and 0.68, respectively. induction of D3 by both TPA and bFGF. Maximal inhibitory effects were noted at PD 98059 concentrations of 30 -40 m, with significant inhibition noted at 10 m. The results of a typical experiment using this reagent at a concentration of 30 or 50 m are shown in Fig. 7 . A marked inhibition of induction of both D3 activity and mRNA levels by TPA (Fig. 7A) and bFGF (Fig. 7B ) was noted. This inhibitory effect also occurred if the pretreatment period with PD 98059 was extended to 24 h (data not shown).
In control studies, we demonstrated that carryover of GF 109203X or PD 98059 into the in vitro D3 assay was not responsible for this impairment in D3 activity; the addition of extracts from cells treated with GF 109203X or PD 98059 into the assay mixture did not impair the D3 activity of extracts from untreated cells.
These findings suggested that the MEK/Erk cascade is a downstream transducer of both the TPA and bFGF stimulatory effects on D3. To further implicate this pathway, Erk (MAP kinase) activity was determined in astroglial cells after exposure to TPA and bFGF. As shown in Fig. 8 , these agents induced a 3-to 4-fold increase in MAP kinase activity, an effect that was largely blocked by pretreatment of cells with 30 m PD 98059.
Given the fundamental differences in the signaling mechanisms of mitogens and growth factors compared with those of agents interacting with nuclear receptors, we anticipated that PD 98059 would not interfere with the induction of D3 activity by T 3 and RA. Data addressing this issue are shown in Table 1 . In control unstimulated astroglial cells, treatment with PD 98059 for 24 h resulted in a small increase in D3 activity from the low basal levels present in these cells. This effect, however, was not seen in short term (8 h) incubations (see Fig. 6 ). The addition of RA or T 3 to the cultures stimulated a large increase in D3 activity after 24 h, as noted previously, and this effect was enhanced an additional 3-fold in cells treated with PD 98059. This potentiation by PD 98059 of the stimulatory effects of RA and T3 was observed in two additional experiments.
Discussion
These studies demonstrate that D3 expression in astroglial cells is regulated by mitogens, growth factors, and hormones, and that exposure to certain combinations of these agents results in synergistic induction of D3 mRNA levels and activity. This complex pattern of regulation may reflect the important role of this enzyme in controlling intracellular T 3 concentrations in the central nervous system of the developing and adult mammal. The compounds tested use distinct signaling mechanisms. This may account for the differences in the degree and rate of D3 induction that were observed with these agents. Thus, compounds that generate signals from the cell surface (i.e. TPA and bFGF) induced rapid increases in D3 mRNA and activity, whereas treatment with ligands that interact with nuclear receptors (T 3 and RA) result in slower effects. Under all conditions, however, the increase in D3 mRNA levels suggests that pretranslational mechanisms mediate at least in part the induction of D3 activity. Such mechanisms are consistent with the known effects of these growth factors and ligands on altering rates of gene transcription (31, 32) , although other mechanisms affecting mRNA stability could be involved.
The synergistic effects of T 3 with TPA or bFGF on stimulating D3 mRNA and activity are striking, and we are not aware of other instances where this has been described for this combination of reagents. The mechanism(s) responsible for this effect is uncertain, but could involve synergistic effects on activating transcription, stabilization of D3 mRNA by T 3 , as has been demonstrated for several other mRNAs (33) (34) (35) , or T 3 -induced alterations in the MEK/Erk cascade. Information concerning the latter possibility has not been published previously; however, we have recently demonstrated that T 3 and RA do not activate Erk in cultured astrocytes during an 18-h incubation (Munsch, N., and M. Pierre, unpublished observations).
An additional finding in these studies was the transient nature of the D3 mRNA induction by TPA; levels peaked at 7 h of treatment and had nearly returned to baseline by 12 h. Such short-lived effects were not noted after T 3 or RA treatment, conditions in which mRNA levels progressively increased for 48 h. This protracted increase in D3 mRNA along with the relatively long half-life for the D3 protein may explain in part why D3 activity progressively increases to quite high levels during 48 h of treatment with T 3 or RA despite the finding that these agents induces relatively small increases in mRNA levels. Alternatively, this dichotomy may reflect alterations in posttranslational processes.
Our finding that 1 m GF 109203X almost completely blocks the induction of D3 by TPA implicates PKC isoforms as the principal upstream mediators of the effect of this agent. In contrast, induction by bFGF was only partially inhibited by GF 109203X, even at higher concentrations. This suggests that pathways not involving classical PKC isoforms are probably involved in D3 induction by bFGF, a finding consistent with the known mechanism of action of this growth factor to activate its receptor tyrosine kinase (13) . With both TPA and bFGF, however, downstream activation of the MEK/Erk cascade appears to be essential for D3 induction. This conclusion is based on the observations that 1) TPA and bFGF at doses that induce D3 expression also activate Erk; and 2) PD 98059 at relatively low concentrations significantly impairs the inductive effects of these agents. Of importance, others have demonstrated the high degree of specificity of PD 98059 for inhibiting MEK; at the concentrations used in our studies, this compound does not inhibit Raf kinase, cAMP-dependent kinase, PKC, v-Src, phosphatidylinositol 3-kinase, or a number of growth factor receptor kinases (30) . However, our finding that PD 98059 only partially inhibits D3 induction may imply that pathways other than MEK/Erk also play a role in the stimulatory effects of mitogens and growth factors. Alternatively, this partial inhibition may have been secondary to the relatively low concentrations of PD 98059 used in our studies.
A striking and consistent 3-to 4-fold increase was noted in the stimulatory effects of T 3 and RA on D3 activity in the presence of PD 98059. This suggests that the MEK/Erk cascade may, under basal conditions, limit the inductive effects of these nuclear ligands on D3 expression. However, given that the experiments with T 3 and RA involved treatment with PD 98059 for 24 h, the potentiating effects of this compound on D3 activity could have been mediated by secondary alterations in other signaling pathways rather than direct inhibition of MEK/Erk activity. Thus, additional studies will be needed to determine the molecular mechanisms responsible for these effects and their physiological significance.
In summary, multiple hormones and growth factors control D3 expression in astroglial cells. Combined with the previously described intricate patterns of regulation of the D2 (36 -38), a picture emerges in which the control of T 3 levels in neural tissue represents an integrated response to a complex array of signals. Although whole animal studies have demonstrated the importance of thyroid status in regulating brain deiodinase activities (3, 39, 40) , the present experiments add to the accumulating evidence that other physiological factors under appropriate circumstances may impact thyroid hormone economy in this tissue. 25 Ϯ 7 9 0 Ϯ 3 Astrocytes were cultured without or with 30 M PD 98059 for 30 min before the addition of 1 M RA or 10 nM T 3 . After 24 h, D3 activity was assayed as described in Fig. 1 . Vehicle (0.1% DMSO) was present in all dishes.
